TrialJournal of atherosclerosis and thrombosis2023

Efficacy and Safety of Prasugrel vs Clopidogrel in Thrombotic Stroke Patients With Risk Factors for Ischemic Stroke Recurrence: A Double-blind, Phase III Study (PRASTRO-III).

Takanari Kitazono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.